Distinct Translational Control in CD4+ T Cell Subsets

PLoS Genetics

Volumn 9, Issue 5, 2013, Pages

  Bjur, Eva ^a,b   Larsson, Ola ^c,e   Yurchenko, Ekaterina ^a,b   Zheng, Lei ^a,b   Gandin, Valentina ^c   Topisirovic, Ivan ^c,f   Li, Shui ^d   Wagner, Carston R ^d   Sonenberg, Nahum ^c   Piccirillo, Ciriaco A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d University of Minnesota   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4E; INTERLEUKIN 2; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE REGULATION; CELL LINEAGE; GENETIC ASSOCIATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TRANSLATION REGULATION;

CD4-POSITIVE T-LYMPHOCYTES; EUKARYOTIC INITIATION FACTOR-4E; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EUKARYOTA;

EID: 84878513440     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003494     Document Type: Article

References (46)

1. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, et al. (2011) Global quantification of mammalian gene expression control. Nature 473: 337-342.
2. Vogel C, Abreu Rde S, Ko D, Le SY, Shapiro BA, et al. (2010) Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol Syst Biol 6: 400.
3. Gygi SP, Rochon Y, Franza BR, Aebersold R, (1999) Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19: 1720-1730.
4. Lu R, Markowetz F, Unwin RD, Leek JT, Airoldi EM, et al. (2009) Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature 462: 358-362.
5. Persson O, Brynnel U, Levander F, Widegren B, Salford LG, et al. (2009) Proteomic expression analysis and comparison of protein and mRNA expression profiles in human malignant gliomas. Proteomics Clin Appl 3: 83-94.
6. Washburn MP, Koller A, Oshiro G, Ulaszek RR, Plouffe D, et al. (2003) Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 100: 3107-3112.
7. Wong WF, Kohu K, Chiba T, Sato T, Satake M, (2011) Interplay of transcription factors in T cell differentiation and function: the role of Runx. Immunology 132: 157-164.
8. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, et al. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212: 8-27.
9. Sakaguchi S, Yamaguchi T, Nomura T, Ono M, (2008) Regulatory T cells and immune tolerance. Cell 133: 775-787.
10. Zhu J, Paul WE, (2008) CD4 T cells: fates, functions, and faults. Blood 112: 1557-1569.
11. Feuerer M, Hill JA, Kretschmer K, von Boehmer H, Mathis D, et al. (2010) Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc Natl Acad Sci U S A 107: 5919-5924.
12. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY, (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6: 1142-1151.
13. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, et al. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
14. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, et al. (2007) Foxp3-dependent programme of regulatory T cell differentiation. Nature 445: 771-775.
15. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, et al. (2007) Foxp3 transcription-factor-dependent and-independent regulation of the regulatory T cell transcriptional signature. Immunity 27: 786-800.
16. Grolleau A, Bowman J, Pradet-Balade B, Puravs E, Hanash S, et al. (2002) Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J Biol Chem 277: 22175-22184.
17. Garcia-Sanz JA, Mikulits W, Livingstone A, Lefkovits I, Mullner EW, (1998) Translational control: a general mechanism for gene regulation during T cell activation. FASEB J 12: 299-306.
18. Mikulits W, Pradet-Balade B, Habermann B, Beug H, Garcia-Sanz JA, et al. (2000) Isolation of translationally controlled mRNAs by differential screening. FASEB J 14: 1641-1652.
19. Sonenberg N, Hinnebusch AG, (2009) Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136: 731-745.
20. Larsson O, Sonenberg N, Nadon R, (2010) Identification of differential translation in genome wide studies. Proc Natl Acad Sci U S A 107 (50):: 21487-21492.
21. Larsson O, Sonenberg N, Nadon R, (2011) anota: analysis of differential translation in genome wide studies. Bioinformatics 27 (10):: 1440-1.
22. Feuerer M, Hill JA, Mathis D, Benoist C, (2009) Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 10: 689-695.
23. Keene JD, (2007) RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 8: 533-543.
24. Mukherjee N, Lager PJ, Friedersdorf MB, Thompson MA, Keene JD, (2009) Coordinated posttranscriptional mRNA population dynamics during T cell activation. Mol Syst Biol 5: 288.
25. Hogan DJ, Riordan DP, Gerber AP, Herschlag D, Brown PO, (2008) Diverse RNA-binding proteins interact with functionally related sets of RNAs, suggesting an extensive regulatory system. PLoS Biol 6: e255 doi:10.1371/journal.pbio.0060255.
26. Luo W, Friedman MS, Shedden K, Hankenson KD, Woolf PJ, (2009) GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 10: 161.
27. Larsson O, Li S, Issaenko OA, Avdulov S, Peterson M, et al. (2007) Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors. Cancer Res 67: 6814-6824.
28. Mamane Y, Petroulakis E, Martineau Y, Sato TA, Larsson O, et al. (2007) Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. PLoS ONE 2: e242 doi:10.1371/journal.pone.0000242.
29. Dowling RJ, Topisirovic I, Alain T, Bidinosti M, Fonseca BD, et al. (2010) mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 328: 1172-1176.
30. Larsson O, Perlman DM, Fan D, Reilly CS, Peterson M, et al. (2006) Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure. Nucleic Acids Res 34: 4375-4386.
31. Colina R, Costa-Mattioli M, Dowling RJ, Jaramillo M, Tai LH, et al. (2008) Translational control of the innate immune response through IRF-7. Nature 452: 323-328.
32. Kim YY, Von Weymarn L, Larsson O, Fan D, Underwood JM, et al. (2009) Eukaryotic initiation factor 4E binding protein family of proteins: sentinels at a translational control checkpoint in lung tumor defense. Cancer Res 69: 8455-8462.
33. Bour-Jordan H, Bluestone JA, (2009) Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol Rev 229: 41-66.
34. Thornton AM, Shevach EM, (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188: 287-296.
35. Ghosh B, Benyumov AO, Ghosh P, Jia Y, Avdulov S, et al. (2009) Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation. ACS Chem Biol 4: 367-377.
36. Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, et al. (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30: 832-844.
37. Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, et al. (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 105: 7797-7802.
38. Nikolcheva T, Pyronnet S, Chou SY, Sonenberg N, Song A, et al. (2002) A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes. J Clin Invest 110: 119-126.
39. Villarino AV, Katzman SD, Gallo E, Miller O, Jiang S, et al. (2011) Posttranscriptional silencing of effector cytokine mRNA underlies the anergic phenotype of self-reactive T cells. Immunity 34: 50-60.
40. Mao X, Green JM, Safer B, Lindsten T, Frederickson RM, et al. (1992) Regulation of translation initiation factor gene expression during human T cell activation. J Biol Chem 267: 20444-20450.
41. Fang L, Wang H, Zhou L, Yu D, (2011) FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells. Toxicol Appl Pharmacol 251: 8-15.
42. Huang H, Regan KM, Wang F, Wang D, Smith DI, et al. (2005) Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci U S A 102: 1649-1654.
43. Ouyang W, Beckett O, Ma Q, Paik JH, DePinho RA, et al. (2010) Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol 11: 618-627.
44. Zhou L, Chong MM, Littman DR, (2009) Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.
45. Dai M, Wang P, Boyd AD, Kostov G, Athey B, et al. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175.
46. Boyle EI, Weng S, Gollub J, Jin H, Botstein D, et al. (2004) TermFinder-open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 20: 3710-3715.